Article

Abiraterone in heavily pretreated patients with metastatic castrate-resistant prostate cancer: Final analysis of overall survival

Anti-Cancer Drugs
DOI: 10.1097/CAD.0000000000000258
3Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

Francini, E., Fiaschi, A. I., Petrioli, R., Bianco, V., Laera, L., Francini, F., & Roviello, G. (2015, August 8). Abiraterone in heavily pretreated patients with metastatic castrate-resistant prostate cancer: Final analysis of overall survival. Anti-Cancer Drugs. Lippincott Williams and Wilkins. https://doi.org/10.1097/CAD.0000000000000258

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free